Fortis Healthcare Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 2:04 pm

Market Cap	47,525 Cr.
Current Price	630
High / Low	744/378
Stock P/E	60.4
Book Value	104
Dividend Yield	0.16 %
ROCE	10.3 %
ROE	7.85 %
Face Value	10.0
PEG Ratio	0.91

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Fortis Healthcare Ltd

Competitors of Fortis Healthcare Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
NG Industries Ltd	57.0 Cr.	170	206/136	4.70	124	2.06 %	6.50 %	5.63 %	10.0
Global Longlife Hospital and Research Ltd	25.5 Cr.	24.2	46.4/22.1		25.9	0.00 %	2.51 %	4.72 %	10.0
Gian Lifecare Ltd	18.1 Cr.	17.5	29.0/12.1	4.43	19.2	0.00 %	29.2 %	24.6 %	10.0
Fortis Malar Hospitals Ltd	118 Cr.	62.7	108/44.0	153	15.9	67.8 %	3.29 %	9.12 %	10.0
Family Care Hospitals Ltd	26.7 Cr.	4.95	9.50/4.32	0.70	2.67	0.00 %	15.4 %	24.1 %	10.0
Industry Average	22,314.27 Cr	670.23		53.44	89.39	3.10%	12.34%	12.42%	9.12

All Competitor Stocks of Fortis Healthcare Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	1,467	1,378	1,488	1,607	1,560	1,643	1,657	1,770	1,680	1,786	1,859	1,988	1,928
Expenses	1,180	1,157	1,237	1,304	1,283	1,372	1,386	1,440	1,396	1,405	1,516	1,554	1,553
Operating Profit	287	221	251	303	276	271	272	330	284	381	343	435	375
OPM %	20%	16%	17%	19%	18%	16%	16%	19%	17%	21%	18%	22%	19%
Other Income	20	13	31	75	26	26	10	18	19	17	14	-42	47
Interest	38	30	31	33	33	32	31	32	33	35	35	36	45
Depreciation	76	77	74	77	83	82	79	84	87	92	91	95	97
Profit before tax	193	126	176	268	186	183	171	233	183	271	230	261	279
Tax %	27%	31%	24%	19%	24%	25%	27%	21%	27%	25%	24%	26%	9%
Net Profit	142	87	134	218	142	138	124	184	134	203	174	193	254
EPS in Rs	1.55	0.90	1.62	2.71	1.72	1.76	1.48	2.30	1.78	2.37	2.20	2.34	3.28

Last Updated: February 28, 2025, 7:58 pm

Below is a detailed analysis of the quarterly data for Fortis Healthcare Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹1,928.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,988.00 Cr. (Sep 2024) to ₹1,928.00 Cr., marking a decrease of 60.00 Cr..
For Expenses, as of Dec 2024, the value is ₹1,553.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,554.00 Cr. (Sep 2024) to ₹1,553.00 Cr., marking a decrease of 1.00 Cr..
For Operating Profit, as of Dec 2024, the value is ₹375.00 Cr.. The value appears to be declining and may need further review. It has decreased from 435.00 Cr. (Sep 2024) to ₹375.00 Cr., marking a decrease of 60.00 Cr..
For OPM %, as of Dec 2024, the value is 19.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Sep 2024) to 19.00%, marking a decrease of 3.00%.
For Other Income, as of Dec 2024, the value is ₹47.00 Cr.. The value appears strong and on an upward trend. It has increased from -42.00 Cr. (Sep 2024) to ₹47.00 Cr., marking an increase of ₹89.00 Cr..
For Interest, as of Dec 2024, the value is ₹45.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 36.00 Cr. (Sep 2024) to ₹45.00 Cr., marking an increase of ₹9.00 Cr..
For Depreciation, as of Dec 2024, the value is ₹97.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 95.00 Cr. (Sep 2024) to ₹97.00 Cr., marking an increase of ₹2.00 Cr..
For Profit before tax, as of Dec 2024, the value is ₹279.00 Cr.. The value appears strong and on an upward trend. It has increased from 261.00 Cr. (Sep 2024) to ₹279.00 Cr., marking an increase of ₹18.00 Cr..
For Tax %, as of Dec 2024, the value is 9.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Sep 2024) to 9.00%, marking a decrease of 17.00%.
For Net Profit, as of Dec 2024, the value is ₹254.00 Cr.. The value appears strong and on an upward trend. It has increased from 193.00 Cr. (Sep 2024) to ₹254.00 Cr., marking an increase of ₹61.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 3.28. The value appears strong and on an upward trend. It has increased from ₹2.34 (Sep 2024) to 3.28, marking an increase of ₹0.94.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 8:34 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	3,042	3,492	3,966	4,199	4,574	4,561	4,469	4,632	4,030	5,718	6,298	6,893	7,561
Expenses	3,827	3,430	3,857	4,106	4,220	4,287	4,238	4,022	3,626	4,649	5,196	5,625	6,028
Operating Profit	-785	62	109	92	354	274	231	610	404	1,069	1,101	1,268	1,534
OPM %	-26%	2%	3%	2%	8%	6%	5%	13%	10%	19%	17%	18%	20%
Other Income	2,169	152	92	299	649	-689	228	126	95	367	157	64	36
Interest	461	250	152	133	229	258	337	205	166	147	129	131	152
Depreciation	229	183	235	225	222	239	233	292	291	301	316	342	376
Profit before tax	694	-219	-185	34	552	-912	-110	239	43	988	814	858	1,042
Tax %	25%	5%	2%	-24%	13%	2%	103%	62%	230%	20%	22%	25%
Net Profit	528	-218	-130	42	479	-934	-224	91	-56	790	633	645	824
EPS in Rs	12.34	-4.73	-3.10	0.40	8.14	-19.46	-3.96	0.77	-1.45	7.35	7.80	7.93	10.19
Dividend Payout %	0%	-0%	-1%	0%	0%	0%	0%	0%	0%	0%	13%	13%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-141.29%	40.37%	132.31%	1040.48%	-294.99%	76.02%	140.62%	-161.54%	1510.71%	-19.87%	1.90%
Change in YoY Net Profit Growth (%)	0.00%	181.65%	91.94%	908.17%	-1335.47%	371.01%	64.61%	-302.16%	1672.25%	-1530.59%	21.77%

Fortis Healthcare Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	7%
5 Years:	9%
3 Years:	20%
TTM:	12%

Compounded Profit Growth
10 Years:	17%
5 Years:	43%
3 Years:	136%
TTM:	47%

Stock Price CAGR
10 Years:	15%
5 Years:	35%
3 Years:	34%
1 Year:	53%

Return on Equity
10 Years:	3%
5 Years:	4%
3 Years:	7%
Last Year:	8%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 12:31 am

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	405	463	463	463	518	519	755	755	755	755	755	755	755
Reserves	3,301	3,820	3,585	3,998	4,626	3,543	5,846	5,906	5,365	5,423	6,487	6,908	7,092
Borrowings	7,145	2,550	1,784	1,513	2,217	1,962	2,010	1,594	1,531	1,255	926	1,155	1,186
Other Liabilities	2,662	1,018	1,760	1,257	2,227	2,455	2,875	2,781	3,216	4,082	3,921	4,153	4,563
Total Liabilities	13,514	7,851	7,592	7,232	9,588	8,479	11,486	11,036	10,866	11,516	12,089	12,971	13,597
Fixed Assets	9,274	4,147	4,218	3,642	5,419	4,992	8,477	8,802	8,799	9,416	9,426	9,874	10,172
CWIP	244	147	228	226	268	226	450	204	165	193	228	542	435
Investments	1,187	1,817	1,464	1,452	1,878	1,732	270	175	186	104	210	230	175
Other Assets	2,808	1,739	1,682	1,913	2,023	1,529	2,290	1,856	1,716	1,803	2,225	2,326	2,814
Total Assets	13,514	7,851	7,592	7,232	9,588	8,479	11,486	11,036	10,866	11,516	12,089	12,971	13,597

Below is a detailed analysis of the balance sheet data for Fortis Healthcare Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹755.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹755.00 Cr..
For Reserves, as of Sep 2024, the value is ₹7,092.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹6,908.00 Cr. (Mar 2024) to ₹7,092.00 Cr., marking an increase of 184.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹1,186.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹1,155.00 Cr. (Mar 2024) to ₹1,186.00 Cr., marking an increase of 31.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹4,563.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹4,153.00 Cr. (Mar 2024) to ₹4,563.00 Cr., marking an increase of 410.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹13,597.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹12,971.00 Cr. (Mar 2024) to ₹13,597.00 Cr., marking an increase of 626.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹10,172.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹9,874.00 Cr. (Mar 2024) to ₹10,172.00 Cr., marking an increase of 298.00 Cr..
For CWIP, as of Sep 2024, the value is ₹435.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹542.00 Cr. (Mar 2024) to ₹435.00 Cr., marking a decrease of 107.00 Cr..
For Investments, as of Sep 2024, the value is ₹175.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹230.00 Cr. (Mar 2024) to ₹175.00 Cr., marking a decrease of 55.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹2,814.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹2,326.00 Cr. (Mar 2024) to ₹2,814.00 Cr., marking an increase of 488.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹13,597.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹12,971.00 Cr. (Mar 2024) to ₹13,597.00 Cr., marking an increase of 626.00 Cr..

Notably, the Reserves (₹7,092.00 Cr.) exceed the Borrowings (1,186.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	1,644	479	24	195	966	493	-179	172	485	865	822	1,100
Cash from Investing Activity +	-1,490	2,503	213	122	-1,001	-333	-3,279	63	-131	-501	-372	-889
Cash from Financing Activity +	-74	-3,217	-304	-354	259	-672	4,257	-862	-143	-517	-471	-86
Net Cash Flow	80	-235	-66	-37	225	-513	799	-627	212	-153	-21	125

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-792.00	60.00	108.00	91.00	352.00	273.00	229.00	609.00	403.00	0.00	-925.00	0.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	80	46	38	39	38	38	44	36	41	33	34	33
Inventory Days	43	26	25	23	23	24	22	30	29	33	31	24
Days Payable	413	200	207	218	215	279	296	226	205	178	179	164
Cash Conversion Cycle	-290	-128	-144	-156	-155	-217	-230	-161	-135	-112	-115	-107
Working Capital Days	-133	-16	-69	-24	-33	-76	-133	-116	-37	-21	-12	-115
ROCE %	1%	0%	-0%	3%	11%	3%	6%	4%	2%	10%	10%	10%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	31.17%	31.17%	31.17%	31.17%	31.17%	31.17%	31.17%	31.17%	31.17%	31.17%	31.17%	31.17%
FIIs	29.33%	30.08%	29.82%	29.66%	30.59%	31.01%	31.22%	30.03%	26.31%	23.72%	23.24%	23.31%
DIIs	15.79%	15.67%	16.90%	17.60%	20.02%	20.38%	20.69%	22.17%	26.55%	29.42%	31.14%	32.31%
Public	23.71%	23.08%	22.12%	21.57%	18.22%	17.44%	16.92%	16.65%	15.97%	15.71%	14.44%	13.22%
No. of Shareholders	1,66,743	1,54,572	1,56,881	1,60,762	1,58,455	1,43,519	1,37,894	1,35,047	1,31,516	1,35,664	1,57,165	1,54,260

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
HDFC Mid-Cap Opportunities Fund - Regular Plan	21,353,375	1.44	1015.03	5,485,043	2025-03-11	289.3%
Kotak Emerging Equity Fund - Regular Plan	20,190,278	1.96	959.74	5,485,043	2025-03-11	268.1%
Axis Midcap Fund	13,299,371	2.1	632.19	5,485,043	2025-03-11	142.47%
Nippon India Growth Fund	13,200,000	2.03	627.46	5,485,043	2025-03-11	140.65%
HDFC Small Cap Fund - Regular Plan	12,453,275	1.88	591.97	5,485,043	2025-03-11	127.04%
Mirae Asset Large & Midcap Fund	9,491,563	1.19	451.18	5,485,043	2025-03-11	73.04%
Aditya Birla Sun Life ELSS Tax Saver Fund	8,360,144	2.44	397.4	5,485,043	2025-03-11	52.42%
Mirae Asset Midcap Fund	7,435,461	2.12	353.44	5,485,043	2025-03-11	35.56%
SBI Long Term Equity Fund	7,065,304	1.3	335.85	5,485,043	2025-03-11	28.81%
Kotak Multicap Fund	5,485,043	1.97	260.73	5,485,043	2025-03-11	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	7.93	7.80	7.35	-1.45	0.77
Diluted EPS (Rs.)	7.93	7.80	7.35	-1.45	0.77
Cash EPS (Rs.)	12.96	12.28	14.13	2.48	4.91
Book Value[Excl.RevalReserv]/Share (Rs.)	113.33	107.30	92.83	88.98	95.44
Book Value[Incl.RevalReserv]/Share (Rs.)	113.33	107.30	92.83	88.98	95.44
Revenue From Operations / Share (Rs.)	91.30	83.42	75.73	53.38	61.36
PBDIT / Share (Rs.)	17.30	15.40	14.52	5.97	8.77
PBIT / Share (Rs.)	12.76	11.22	10.54	2.12	4.91
PBT / Share (Rs.)	11.24	10.49	12.76	-0.05	3.01
Net Profit / Share (Rs.)	8.42	8.10	10.14	-1.37	1.05
NP After MI And SOA / Share (Rs.)	7.93	7.80	7.35	-1.45	0.76
PBDIT Margin (%)	18.94	18.46	19.17	11.19	14.29
PBIT Margin (%)	13.97	13.45	13.91	3.98	7.99
PBT Margin (%)	12.30	12.57	16.85	-0.10	4.90
Net Profit Margin (%)	9.22	9.70	13.39	-2.57	1.71
NP After MI And SOA Margin (%)	8.68	9.34	9.70	-2.72	1.25
Return on Networth / Equity (%)	7.81	8.12	8.98	-1.79	0.86
Return on Capital Employeed (%)	9.52	7.69	7.49	1.61	4.22
Return On Assets (%)	4.50	4.73	4.67	-0.98	0.51
Long Term Debt / Equity (X)	0.09	0.07	0.12	0.15	0.14
Total Debt / Equity (X)	0.11	0.09	0.15	0.18	0.19
Asset Turnover Ratio (%)	0.53	0.09	0.07	0.05	0.06
Current Ratio (X)	0.44	0.98	0.89	0.84	0.36
Quick Ratio (X)	0.41	0.90	0.79	0.77	0.33
Dividend Payout Ratio (NP) (%)	12.60	0.00	0.00	0.00	0.00
Dividend Payout Ratio (CP) (%)	8.01	0.00	0.00	0.00	0.00
Earning Retention Ratio (%)	87.40	0.00	0.00	0.00	0.00
Cash Earning Retention Ratio (%)	91.99	0.00	0.00	0.00	0.00
Interest Coverage Ratio (X)	9.97	9.01	7.47	2.72	3.23
Interest Coverage Ratio (Post Tax) (X)	5.73	5.16	4.07	0.36	1.09
Enterprise Value (Cr.)	32853.83	20823.69	23306.97	16352.45	11111.40
EV / Net Operating Revenue (X)	4.77	3.31	4.08	4.06	2.40
EV / EBITDA (X)	25.16	17.90	21.26	36.26	16.78
MarketCap / Net Operating Revenue (X)	4.60	3.12	3.83	3.73	2.05
Retention Ratios (%)	87.39	0.00	0.00	0.00	0.00
Price / BV (X)	4.14	2.71	3.55	2.45	1.43
Price / Net Operating Revenue (X)	4.60	3.12	3.83	3.73	2.05
EarningsYield	0.01	0.02	0.02	-0.01	0.01

After reviewing the key financial ratios for Fortis Healthcare Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 7.93. This value is within the healthy range. It has increased from 7.80 (Mar 23) to 7.93, marking an increase of 0.13.
For Diluted EPS (Rs.), as of Mar 24, the value is 7.93. This value is within the healthy range. It has increased from 7.80 (Mar 23) to 7.93, marking an increase of 0.13.
For Cash EPS (Rs.), as of Mar 24, the value is 12.96. This value is within the healthy range. It has increased from 12.28 (Mar 23) to 12.96, marking an increase of 0.68.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 113.33. It has increased from 107.30 (Mar 23) to 113.33, marking an increase of 6.03.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 113.33. It has increased from 107.30 (Mar 23) to 113.33, marking an increase of 6.03.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 91.30. It has increased from 83.42 (Mar 23) to 91.30, marking an increase of 7.88.
For PBDIT / Share (Rs.), as of Mar 24, the value is 17.30. This value is within the healthy range. It has increased from 15.40 (Mar 23) to 17.30, marking an increase of 1.90.
For PBIT / Share (Rs.), as of Mar 24, the value is 12.76. This value is within the healthy range. It has increased from 11.22 (Mar 23) to 12.76, marking an increase of 1.54.
For PBT / Share (Rs.), as of Mar 24, the value is 11.24. This value is within the healthy range. It has increased from 10.49 (Mar 23) to 11.24, marking an increase of 0.75.
For Net Profit / Share (Rs.), as of Mar 24, the value is 8.42. This value is within the healthy range. It has increased from 8.10 (Mar 23) to 8.42, marking an increase of 0.32.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 7.93. This value is within the healthy range. It has increased from 7.80 (Mar 23) to 7.93, marking an increase of 0.13.
For PBDIT Margin (%), as of Mar 24, the value is 18.94. This value is within the healthy range. It has increased from 18.46 (Mar 23) to 18.94, marking an increase of 0.48.
For PBIT Margin (%), as of Mar 24, the value is 13.97. This value is within the healthy range. It has increased from 13.45 (Mar 23) to 13.97, marking an increase of 0.52.
For PBT Margin (%), as of Mar 24, the value is 12.30. This value is within the healthy range. It has decreased from 12.57 (Mar 23) to 12.30, marking a decrease of 0.27.
For Net Profit Margin (%), as of Mar 24, the value is 9.22. This value is within the healthy range. It has decreased from 9.70 (Mar 23) to 9.22, marking a decrease of 0.48.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 8.68. This value is within the healthy range. It has decreased from 9.34 (Mar 23) to 8.68, marking a decrease of 0.66.
For Return on Networth / Equity (%), as of Mar 24, the value is 7.81. This value is below the healthy minimum of 15. It has decreased from 8.12 (Mar 23) to 7.81, marking a decrease of 0.31.
For Return on Capital Employeed (%), as of Mar 24, the value is 9.52. This value is below the healthy minimum of 10. It has increased from 7.69 (Mar 23) to 9.52, marking an increase of 1.83.
For Return On Assets (%), as of Mar 24, the value is 4.50. This value is below the healthy minimum of 5. It has decreased from 4.73 (Mar 23) to 4.50, marking a decrease of 0.23.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 0.2. It has increased from 0.07 (Mar 23) to 0.09, marking an increase of 0.02.
For Total Debt / Equity (X), as of Mar 24, the value is 0.11. This value is within the healthy range. It has increased from 0.09 (Mar 23) to 0.11, marking an increase of 0.02.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.53. It has increased from 0.09 (Mar 23) to 0.53, marking an increase of 0.44.
For Current Ratio (X), as of Mar 24, the value is 0.44. This value is below the healthy minimum of 1.5. It has decreased from 0.98 (Mar 23) to 0.44, marking a decrease of 0.54.
For Quick Ratio (X), as of Mar 24, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.90 (Mar 23) to 0.41, marking a decrease of 0.49.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 12.60. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 12.60, marking an increase of 12.60.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 8.01. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 23) to 8.01, marking an increase of 8.01.
For Earning Retention Ratio (%), as of Mar 24, the value is 87.40. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 87.40, marking an increase of 87.40.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 91.99. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 91.99, marking an increase of 91.99.
For Interest Coverage Ratio (X), as of Mar 24, the value is 9.97. This value is within the healthy range. It has increased from 9.01 (Mar 23) to 9.97, marking an increase of 0.96.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 5.73. This value is within the healthy range. It has increased from 5.16 (Mar 23) to 5.73, marking an increase of 0.57.
For Enterprise Value (Cr.), as of Mar 24, the value is 32,853.83. It has increased from 20,823.69 (Mar 23) to 32,853.83, marking an increase of 12,030.14.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 4.77. This value exceeds the healthy maximum of 3. It has increased from 3.31 (Mar 23) to 4.77, marking an increase of 1.46.
For EV / EBITDA (X), as of Mar 24, the value is 25.16. This value exceeds the healthy maximum of 15. It has increased from 17.90 (Mar 23) to 25.16, marking an increase of 7.26.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 4.60. This value exceeds the healthy maximum of 3. It has increased from 3.12 (Mar 23) to 4.60, marking an increase of 1.48.
For Retention Ratios (%), as of Mar 24, the value is 87.39. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 23) to 87.39, marking an increase of 87.39.
For Price / BV (X), as of Mar 24, the value is 4.14. This value exceeds the healthy maximum of 3. It has increased from 2.71 (Mar 23) to 4.14, marking an increase of 1.43.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 4.60. This value exceeds the healthy maximum of 3. It has increased from 3.12 (Mar 23) to 4.60, marking an increase of 1.48.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 23) to 0.01, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Fortis Healthcare Ltd as of March 12, 2025 is: ₹395.12

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Fortis Healthcare Ltd is Overvalued by 37.28% compared to the current share price 630.00

Intrinsic Value of Fortis Healthcare Ltd as of March 12, 2025 is: 656.26

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Fortis Healthcare Ltd is Undervalued by 4.17% compared to the current share price 630.00

Last 5 Year EPS CAGR: 66.09%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -65.42, which is a positive sign. The stock has a low average Cash Conversion Cycle of -162.50, which is a positive sign. The company has higher reserves (5,069.23 cr) compared to borrowings (2,063.69 cr), indicating strong financial stability. The company has shown consistent growth in sales (4.38 cr) and profit (215.15 cr) over the years.	The stock has a low average ROCE of 5.00%, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fortis Healthcare Ltd:
1. Net Profit Margin: 9.22%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 9.52% (Industry Average ROCE: 12.34%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 7.81% (Industry Average ROE: 12.42%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 5.73
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.41
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 60.4 (Industry average Stock P/E: 53.44)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.11
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Fortis Healthcare Ltd. is a Public Limited Listed company incorporated on 28/02/1996 and has its registered office in the State of Punjab, India. Company's Corporate Identification Number(CIN) is L85110PB1996PLC045933 and registration number is 045933. Currently Company is involved in the business activities of Hospital activities. Company's Total Operating Revenue is Rs. 1181.42 Cr. and Equity Capital is Rs. 754.96 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Hospitals & Medical Services	Fortis Hospital, Mohali Punjab 160062	secretarial@fortishealthcare.com http://www.fortishealthcare.com

Management
Name	Position Held
Mr. Ravi Rajagopal	Chairperson & Independent Director
Dr. Ashutosh Raghuvanshi	Managing Director & CEO
Ms. Suvalaxmi Chakraborty	Independent Director
Mr. Indrajit Banerjee	Independent Director
Ms. Shailaja Chandra	Independent Director
Mr. Tomo Nagahiro	Non Executive Director
Mr. Dilip Kadambi	Non Executive Director
Mr. Lim Tsin Lin	Non Executive Director
Mr. Mehmet Ali Aydinlar	Non Executive Director
Dr. Prem Kumar Nair	Non Executive Director
Mr. Ashok Pandit	Non Executive Director

FAQ

What is the latest intrinsic value of Fortis Healthcare Ltd?

The latest intrinsic value of Fortis Healthcare Ltd as on 10 March 2025 is ₹395.12, which is 37.28% lower than the current market price of 630.00, indicating the stock is overvalued by 37.28%. The intrinsic value of Fortis Healthcare Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹47,525 Cr. and recorded a high/low of ₹744/378 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹7,092 Cr and total liabilities of ₹13,597 Cr.

What is the Market Cap of Fortis Healthcare Ltd?

The Market Cap of Fortis Healthcare Ltd is 47,525 Cr..

What is the current Stock Price of Fortis Healthcare Ltd as on 10 March 2025?

The current stock price of Fortis Healthcare Ltd as on 10 March 2025 is ₹630.

What is the High / Low of Fortis Healthcare Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Fortis Healthcare Ltd stocks is ₹744/378.

What is the Stock P/E of Fortis Healthcare Ltd?

The Stock P/E of Fortis Healthcare Ltd is 60.4.

What is the Book Value of Fortis Healthcare Ltd?

The Book Value of Fortis Healthcare Ltd is 104.

What is the Dividend Yield of Fortis Healthcare Ltd?

The Dividend Yield of Fortis Healthcare Ltd is 0.16 %.

What is the ROCE of Fortis Healthcare Ltd?

The ROCE of Fortis Healthcare Ltd is 10.3 %.

What is the ROE of Fortis Healthcare Ltd?

The ROE of Fortis Healthcare Ltd is 7.85 %.

What is the Face Value of Fortis Healthcare Ltd?

The Face Value of Fortis Healthcare Ltd is 10.0.